Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRX.L Regulatory News (CRX)

  • There is currently no data for CRX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Cyprotex Plc

6 Apr 2016 09:19

RNS Number : 3479U
Nplus1 Singer Capital Markets Ltd
06 April 2016
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED IN,TERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Cyprotex Plc

 

(c) Name of the party to the offer with which exempt principal trader is connected:

 

Cyprotex Plc

 

(d) Date dealing undertaken:

05 April 2016

 

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 7P

 

Sale

 

3,992

 

100.189p

 

100.189p

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

Date of disclosure:

06 April 2016

Contact name:

Kelly Morgan

Telephone number:

020 7496 3094

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERAKADDFBKKOQK
Date   Source Headline
14th Dec 20164:03 pmRNSScheme of Arrangement becomes effective
14th Dec 20167:30 amRNSSuspension - Cyprotex Plc
13th Dec 20163:32 pmRNSDirector Dealing
13th Dec 201611:46 amRNSCourt Sanction of Scheme of Arrangement
9th Dec 20169:38 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
7th Dec 201610:02 amRNSForm 8.5 (EPT/RI) Cyprotex plc
6th Dec 20169:04 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
5th Dec 20166:34 pmRNSForm 8.3 - Cyprotex PLC
5th Dec 20166:34 pmRNSForm 8.3 - Cyprotex Plc
5th Dec 20169:12 amRNSForm 8.3 - Cyprotex PLC
2nd Dec 20161:45 pmRNSForm 8.3 - Cyprotex PLC
2nd Dec 20161:37 pmRNSForm 8.3 - Cyprotex PLC
2nd Dec 20168:45 amRNSForm 8.3 - Cyprotex PLC
1st Dec 20161:40 pmRNSResults of Court Meeting & General Meeting
1st Dec 20169:08 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
1st Dec 20168:23 amRNSForm 8.3 - Cyprotex PLC
30th Nov 20169:06 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
29th Nov 201610:31 amRNSForm 8.3 - CYPROTEX PLC
29th Nov 20169:46 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
29th Nov 20167:00 amRNSLaunch of in vitro h-CLAT Service
28th Nov 201610:52 amRNSForm 8.3 - CYPROTEX PLC
28th Nov 20169:18 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
25th Nov 20169:04 amRNSForm 8.5 (EPT/RI) Cyprotex plc
23rd Nov 20169:17 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
22nd Nov 20169:05 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
21st Nov 20169:04 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
16th Nov 20169:24 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
15th Nov 20168:39 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
14th Nov 20169:38 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
11th Nov 20167:00 amRNSDirector Dealing
10th Nov 20169:18 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
9th Nov 20169:53 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
8th Nov 201610:01 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
7th Nov 20169:27 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
4th Nov 20167:00 amRNSPosting of Scheme Document
2nd Nov 201610:09 amRNSForm 8.5 (EPT/RI) Cyprotex Plc
1st Nov 20169:09 amRNSForm 8.5 (EPT/RI) Cyprotex
27th Oct 201612:39 pmRNSForm 8.5 (EPT/RI) CYPROTEX PLC
27th Oct 201610:11 amPRNForm 8.3 - Cyprotex Plc - Amendment
26th Oct 20169:08 amRNSForm 8.5 (EPT/RI) CYPROTEX PLC
26th Oct 20167:00 amRNSRule 2.7 Announcement: Recommended Offer
25th Oct 20169:23 amRNSForm 8.5 (EPT/RI) CYPROTEX PLC
21st Oct 20163:31 pmRNSDirector Declaration
21st Oct 20169:59 amRNSForm 8.5 (EPT/RI) CYPROTEX PLC
20th Oct 20168:57 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc
18th Oct 20169:22 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
14th Oct 20169:16 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
13th Oct 20169:46 amRNSForm 8.5 (EPT/RI) - Cyprotex PLC
13th Oct 20167:00 amRNSCyprotex PLC - Rule 2.9 Announcement
11th Oct 20169:19 amRNSForm 8.5 (EPT/RI) - Cyprotex Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.